Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Incyclix Bio

Clinical trials sponsored by Incyclix Bio, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New pill INX-315 takes on advanced breast and ovarian cancers Results expected Jul 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

New pill INX-315 takes on advanced breast and ovarian cancers

Disease control Recruiting now

This study tests a new oral drug called INX-315 in 150 people with advanced breast cancer, ovarian cancer, or other solid tumors that have not responded to standard treatments. The drug is given alone or combined with other cancer drugs (fulvestrant or abemaciclib). The goal is t…

Phase 1/2 • Sponsor: Incyclix Bio • Aim: Disease control

Last updated Jun 27, 2026 12:02 UTC